Related Experiment Video
Updated: Jul 10, 2026

Robotic Myotomy and Partial Fundoplication for Achalasia
Published on: August 11, 2023
Minimally invasive myotomy for achalasia in the elderly
Arman Kilic1, Matthew J Schuchert, Arjun Pennathur
1Heart, Lung, and Esophageal Surgery Institute, University of Pittsburgh Medical Center, 200 Lothrop St., Suite C-800, Pittsburgh, PA, Pennsylvania, 15261, USA.
Background:
Elderly patients with achalasia are more frequently being referred for minimally invasive Heller myotomy (MIM). The associated morbidity and mortality of MIM in the elderly are not well defined. The objective of this study was to review our experience with MIM in the elderly.
Methods:
We identified a total of 57 patients (32 men, 25 women) 70 years or older (mean age 78 years, range 70 to 96 years) who underwent MIM [55 laparoscopically (LAP), 2 videothoracoscopically (VATS)] for achalasia at our institution. Clinical outcomes were analyzed including postoperative surgical interventions (redo myotomy, esophagectomy), and dysphagia scores (range: 1, no dysphagia to 5, dysphagia to saliva).
Results:
Thirty-seven (59.6%) patients had prior endoscopic therapy. There was no perioperative mortality and median hospital stay was 3 days. There were three (5.3%) conversions to open due to adhesions and concern regarding the viability of the myotomy following repair of a small perforation. A total of 11 (19.3%) patients had complications, including three (5.3%) intraoperative esophageal perforations, three pleural effusions, one (1.8%) pneumonia, one intraoperative gastric perforation, one C. difficile infection, one ileus, and one postoperative intubation. Mean follow-up was 23.5 months. Mean dysphagia score improved from 3.38 preoperatively to 1.36 following MIM (p < 0.0001), with 55 (96.5%) patients experiencing an improvement. Reoperation for recurrent dysphagia was required in four (7.0%) of the patients.
Conclusions:
MIM can be performed safely in elderly patients with achalasia in centers with significant experience in laparoscopic foregut surgery. MIM affords similar symptomatic improvement in the elderly as compared to younger patients. MIM should be seriously considered as a therapeutic strategy in elderly achalasia patients.
Insights
Minimally invasive Heller myotomy (MIM) is a safe and effective treatment for achalasia in elderly patients, offering significant symptom improvement. This procedure should be strongly considered for older individuals with this condition.
Area of Science:
- Gastroenterology
- Surgical Innovation
- Geriatric Medicine
Background:
- Elderly patients with achalasia are increasingly undergoing minimally invasive Heller myotomy (MIM).
- The risks and outcomes of MIM in this demographic are not fully understood.
- This study reviews institutional experience with MIM in elderly achalasia patients.
Purpose of the Study:
- To evaluate the safety and efficacy of minimally invasive Heller myotomy (MIM) in patients aged 70 years and older with achalasia.
- To define the morbidity and mortality associated with MIM in the elderly population.
- To compare outcomes of MIM in elderly patients to younger cohorts.
Main Methods:
- Retrospective analysis of 57 patients (≥70 years) who underwent MIM for achalasia.
- Procedures were primarily laparoscopic (55) with two videothoracoscopic approaches.
- Outcomes assessed included postoperative interventions and dysphagia scores (1-5 scale).
Main Results:
- No perioperative mortality; median hospital stay was 3 days.
- 19.3% of patients experienced complications, including esophageal perforations and pneumonia.
- Significant improvement in mean dysphagia score from 3.38 to 1.36 (p < 0.0001), with 96.5% reporting improvement.
Conclusions:
- Minimally invasive Heller myotomy (MIM) is safe for elderly achalasia patients in experienced centers.
- MIM provides comparable symptomatic relief in the elderly to younger patients.
- MIM is a viable therapeutic option for achalasia in older adults.
Related Concept Videos
Esophageal Achalasia
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Skeletal Muscle Relaxants: Therapeutic Uses
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...

